Home / Wiki / M / Multiomics

Multiomics

Investment and Capital MarketsUpdated 16 Nov 2026

Multiomics is an approach to biological research that combines several large-scale datasets from the same samples in order to study a living system as a whole. The layers usually include genomics, which reads DNA, epigenomics, which records chemical marks that switch genes on and off, proteomics, which measures proteins, and metabolomics, which measures small molecules. Each layer gives a partial view. Analysed together, usually with machine learning, they can show how a genetic difference leads to a change in the body and eventually to disease.

The approach is used in drug discovery, in cancer research and in the development of molecular diagnostics. Its commercial base is the makers of sequencing machines, laboratory instruments and analysis software, followed by companies that sell tests. In thematic investing it is grouped with precision medicine and longevity. The data are costly to produce and hard to integrate, and many findings have yet to be proven useful in clinical practice.

Last updated 16 Nov 2026